Cue Biopharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cue Biopharma Inc
CIK #0001645460
EDGAR Form CIK 2011 - 2026
10-K [0001645460]
10-Q [0001645460]
3 [0001645460]
4 [0001645460]
5 [0001645460]
8-K [0001645460]
D [0001645460]
SC 13D [0001645460]
SC 13G [0001645460]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bleichroeder LP Cue Biopharma Inc [2024-03-11]
BlackRock Inc Cue Biopharma Inc [2024-02-07]
BlackRock Inc Cue Biopharma Inc [2024-01-31]
Slate Path Capital LP Cue Biopharma Inc [2023-02-14]
Slate Path Capital LP Cue Biopharma Inc [2022-11-18]
BlackRock Inc Cue Biopharma Inc [2022-07-08]
State Street Corp Cue Biopharma Inc [2022-02-10]
Corriente Advisors LLC Cue Biopharma Inc [2021-02-16]
Avoro Capital Advisors LLC Cue Biopharma Inc [2020-02-14]
Nantahala Capital Management LLC Cue Biopharma Inc [2020-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Meluzio Michael Vincent
Cue Biopharma Inc
Ray Sumita
Camardo Daniel A
Lin Shao-Lee
Meehan Viola Mong
Baker Daniel G
Sandercock Colin
Warren Lucinda
Morich Frank
Kiener Peter A
Broadfoot Jill Marie
Garzone Pamela
Verheyen Patrick
Sarraf Pasha
Azam Usman
Passeri Daniel R
Millar Kerri-Ann
Levisetti Matteo
Driscoll Frederick W
Fox Michael J
Suri Anish
Nasshorn Patricia
Howson Tamar D
Fletcher Aaron GL
Gray Cameron
Pienta Kenneth
Simon Barry J
Marlett Christopher A
McKnight Steven L
Mancilla Bethany
Digiandomenico Anthony
Chaparro Rodolfo
Seidel Ronald D III
Schuman Gary Alan
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2026-01-02 Grant 24,400 $0.00
Cue Biopharma Inc CUE
Common Stock
2025-12-30 Buy 77,417 $0.30 23,225
Cue Biopharma Inc CUE
Common Stock
2025-12-30 Buy 86,947 $0.32 27,823
Cue Biopharma Inc CUE
Common Stock
2025-12-30 Buy 77,148 $0.30 23,144
Cue Biopharma Inc CUE
Common Stock
2025-12-30 Buy 4,229 $0.31 1,311
Cue Biopharma Inc CUE
Common Stock
2025-12-30 Buy 78,116 $0.31 24,216
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-12-03 Grant 70,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-09-29 Grant 125,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-09-29 Grant 50,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-09-29 Grant 1,875,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-09-26 Grant 30,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-06-04 Grant 48,800 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-03-21 Grant 450,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-03-21 Grant 200,000 $0.00
Cue Biopharma Inc CUE
Stock Option (right to buy) · derivative
2025-03-21 Grant 100,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com